Zentalis Pharmaceuticals Inc (ZNTL)
12.56
+0.04
(+0.32%)
USD |
NASDAQ |
May 10, 16:00
12.56
0.00 (0.00%)
After-Hours: 19:42
Zentalis Pharmaceuticals Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2024
--
Maximum
Mar 2024
--
Average
--
Median
Mar 2024
Debt to Equity Ratio Benchmarks
Revolution Medicines Inc | 0.00 |
Day One Biopharmaceuticals Inc | -- |
Perspective Therapeutics Inc | 0.0229 |
Electromed Inc | 0.00 |
Xtant Medical Holdings Inc | 0.4243 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 557.48M |
Total Liabilities (Quarterly) | 98.71M |
Shareholders Equity (Quarterly) | 458.77M |
Current Ratio | 9.194 |